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Abstract The purpose of this systematic review was to
assess the effects of spinal manipulative therapy (SMT),
acupuncture and herbal medicine for chronic non-specific
LBP. A comprehensive search was conducted by an
experienced librarian from the Cochrane Back Review
Group (CBRG) in multiple databases up to December 22,
2008. Randomised controlled trials (RCTs) of adults with
chronic non-specific LBP, which evaluated at least one
clinically relevant, patient-centred outcome measure were
included. Two authors working independently from one
another assessed the risk of bias using the criteria rec-
ommended by the CBRG and extracted the data. The data
were pooled when clinically homogeneous and statisti-
cally possible or were otherwise qualitatively described.
GRADE was used to determine the quality of the evi-
dence. In total, 35 RCTs (8 SMT, 20 acupuncture, 7
herbal medicine), which examined 8,298 patients, fulfilled
the inclusion criteria. Approximately half of these (2
SMT, 8 acupuncture, 7 herbal medicine) were thought to
have a low risk of bias. In general, the pooled effects for
the studied interventions demonstrated short-term relief or
improvement only. The lack of studies with a low-risk of
bias, especially in regard to SMT precludes any strong
conclusions; however, the principal findings, which are
based upon low- to very-low-quality evidence, suggest
that SMT does not provide a more clinically beneficial
effect compared with sham, passive modalities or any
other intervention for treatment of chronic low-back pain.
There is evidence, however, that acupuncture provides a
short-term clinically relevant effect when compared with
a waiting list control or when acupuncture is added to
another intervention. Although there are some good
results for individual herbal medicines in short-term
individual trials, the lack of homogeneity across studies
did not allow for a pooled estimate of the effect. In
general, these results are in agreement with other recent
systematic reviews on SMT, but in contrast with others.
These results are also in agreement with recent reviews
on acupuncture and herbal medicine. Randomized trials
with a low risk of bias and adequate sample sizes are
direly needed.
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Introduction
Low-back pain (LBP) is a common and disabling disorder
in western society, which represents a great financial burden
in the form of direct costs resulting from loss of work and
medical expenses, as well as indirect costs [28, 29, 76].
Effective and adequate treatment is an important issue for
patients, clinicians and policy makers. In addition to tradi-
tional interventions for LBP, such as medication, exercise
or behavioural therapy, therapies collectively called com-
plementary and alternative medicine (CAM) are commonly
used. This includes, for example, spinal manipulative
therapy (SMT), acupuncture and herbal medicine. The
effectiveness of these therapies for the treatment of chronic
non-specific LBP is not without dispute; therefore, a sys-
tematic review was conducted in order to assess the effec-
tiveness of CAM therapies for the treatment of chronic
non-specific LBP.
Methods
Criteria for considering studies for this review
Types of studies
Only randomised controlled trials (RCT) on SMT, acu-
puncture and herbal medicine were considered.
Types of participants
A study must have fulfilled the following criteria: (1) RCT
with at least 1 day of follow-up; (2) adult (C18 years of
age) subjects with chronic (C12 weeks) non-specific LBP
(including discopathy or any other non-specific degenera-
tive pathology, such as degeneration or osteoarthritis); (3)
evaluated at least one main clinically-relevant outcome
measure (i.e. pain, functional status, recovery, or sick-
leave) using a valid instrument; and (4) fulfilled the oper-
ational definition of the therapy evaluated. In addition, the
unique contribution of the CAM therapy must have been
able to be discerned, which excludes studies with a multi-
modal treatment in which the comparison was another type
of intervention.
The following studies were excluded: (1) those in which
specific spinal conditions were examined, specifically
radiculopathies confirmed by radiodiagnostic procedures
(i.e. MRI, CT), electrodiagnosis (i.e. EMG), positive
Lasegue’s or any other study in which subjects with clear
neurological deficits were included, spondylolisthesis,
vertebral spinal stenosis, ankylosing spondylitis, scoliosis,
or coccydynia; (2) post-partum LBP or pelvic pain due to
pregnancy; (3) post-operative studies; (4) primary or
secondary prevention studies; and (5) abstracts or non-
published studies.
Types of interventions
The operational definitions as defined in the individual
Cochrane reviews were maintained. SMT is defined as any
hands-on treatment and includes both manipulation and
mobilization [3]. Acupuncture is defined according to tra-
ditional acupuncture theory, and the needles were required
to be inserted in classical meridian points, extra points or
ah-shi points (painful points) [31]. Studies were excluded if
the acupuncture treatment did not involve needling, such as
acupressure or laser acupuncture. Herbal medicine is defined
as all or part of a plant that was used for medicinal purposes,
administered orally (ingestion) or applied topically. This
excludes plant substances that were smoked, individual
chemicals that were derived from plants or synthetic
chemicals that were based on constituents of plants [32].
Types of outcome measures
Primary outcomes
The following self-reported measures were assessed: pain,
back-specific functional status, perceived recovery (e.g.
subjective overall improvement, proportion of patients
recovered) and lost days at work (e.g. return to work status,
number of days off work or with sick-leave). Physiological
variables, such as spinal flexibility and number of degrees
of straight leg raising were not assessed since it is believed
that these outcomes correlate poorly with the clinical status
of the patient.
Search methods for identification of studies
Existing Cochrane reviews for the three interventions were
screened for studies fulfilling the inclusion criteria. The
searches were updated from the last date that the literature
was searched from these individual reviews.
Electronic searches
The primary search was conducted by an experienced
librarian from the Cochrane Back Review Group (CBRG)
in MEDLINE, EMBASE, CINAHL, CENTRAL (the
Cochrane Central Register of Controlled Trials) and PEDro
up to December 22, 2008.
Searching other resources
References from the relevant studies were also screened
and experts approached in order to identify additional
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primary studies not previously identified. The language
was limited to English, Dutch and German. The search
strategy outlined by the CBRG was followed. The full
search strategy is available upon request from the primary
author.
Data collection and analysis
Selection of studies
Two reviewers (SMR, MM) working independently of one
another examined all citations from the electronic search,
and full articles were obtained for those citations thought to
fulfil the inclusion criteria. A third reviewer was consulted
(MWvT), if consensus was not reached.
Assessment of risk of bias of included studies
Two reviewers working independently of one another
assessed the risk of bias and performed data extraction.
Risk of bias was assessed using the criteria list advised by
the CBRG, which consists of 11-items evaluating internal
validity. Items were scored as positive if they did fulfil the
criteria, negative when bias was likely or marked as
inconclusive if there was insufficient information. Differ-
ences in the scoring and data extraction were discussed
during a consensus meeting. A study with a low risk of bias
was defined as fulfilling six or more of the validity items.
Studies with a fatal flaw were excluded from the meta-
analyses: pre-defined as studies with a drop-out rate higher
than 50% at the first follow-up measurement or statistically
significant and clinically important baseline differences for
the principal outcome measures that were not accounted for
in the analyses. This definition is consistent with an earlier
Cochrane review [31].
Data extraction
An a priori list of items was used for the data extraction,
consisting of both descriptive data (e.g. study population,
type of intervention) and quantitative data regarding the
primary and secondary outcome measures. When the
measure of variation was missing for the follow-up mea-
surements, baseline measures were used. Data were not
extracted when no measure of variation was presented
anywhere in the study (3 older RCTs with a high risk of
bias [22, 49, 53]). Missing outcome data were requested for
three studies [37, 52, 77] and received from the corre-
sponding authors for two [52, 77]. In one RCT with mul-
tiple interventions, two different forms of exercise (i.e.
general exercise plus motor exercise) were combined in
order to create a single pair-wise comparison [26]. In
another study, data were averaged for morning and evening
pain, although there was a negligible difference between
the two sets of data [15]. Data investigating the effect of
different dosages of herbal medicine versus a placebo were
also combined to form a single pair-wise comparison
[17, 18].
Statistical analysis
Comparison therapies were combined into the following
main clusters of presumed effectiveness: (1) no treatment
or waiting list control, (2) sham, placebo, or passive
modalities, (3) CAM (SMT, acupuncture, or herbal medi-
cine) plus any intervention versus any intervention alone
and (4) any other intervention (e.g. specific exercises,
standard care). Regardless of eventual heterogeneity, the
following stratified analyses were planned a priori: (1) the
intervention (SMT, acupuncture, herbal medicine); (2)
outcome (pain, functional status, perceived recovery); (3)
time of follow-up (defined as short-term: 1 month; inter-
mediate: 3 and 6 months; long-term: 12 months); and (4)
risk of bias (low vs. high risk of bias). Lost days at work or
number of days with sick-leave were not examined as an
outcome because too few studies consistently recorded this
[15, 38, 52, 61]. Sensitivity analyses were conducted in
order to examine heterogeneity, which was tested by the Q-
test (chi-square) and I2. In addition, the type of contrast
intervention was also examined in sensitivity analyses.
Adverse effects were not assessed because this was spar-
sely and inconsistently reported.
Effect size calculations
A mean weighted difference (MWD) was used for pain.
Scales were converted to 100-points, where necessary. In
all but one study, pain was measured using a VAS or
numerical rating scale. The one exception was an acu-
puncture study [40], which measured pain according to the
von Korff Chronic Pain Grade scale [75]. A number of
different instruments were used to measure functional
status [i.e. Roland-Morris Disability Questionnaire
(RMDQ) [5, 63], Oswestry Disability Index (ODI) [5],
Hannover Functional Ability Questionnaire (HFAQ) [41,
48], the Pain Disability Index (PDI) [66] and the Aberdeen
LBP scale [79]]; therefore, standardized mean differences
(SMD) were calculated. A negative effect size indicated
that CAM was more beneficial than the comparison ther-
apy, i.e. it improved function or diminished pain. For
dichotomous outcomes, a risk ratio (RR) was calculated
and the event was defined as the number of subjects
recovered. A random-effects model was used for all mod-
elling. Funnel plots were to be examined for publication
bias; however, the few number of studies identified per
outcome did not make this feasible. For each treatment
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comparison, an effect size and a 95% confidence interval
(CI) were calculated. All analyses were conducted in
Review Manager 5.0.
Quality of the evidence
GRADE (Grades of Recommendation, Assessment,
Development and Evaluation) was used to evaluate the
overall quality of the evidence and the strength of the
recommendations [4]. Quality of the evidence for a specific
outcome is based upon five principal measures: (1) limi-
tations (due to for example, study design), (2) consistency
of results, (3) directness (e.g. generalizability of the find-
ings), (4) precision (e.g. sufficient data) and (5) other
considerations, such as reporting bias. The overall quality
is considered to be high when RCTs with a low risk of bias
provide consistent, generalizable and precise results for a
particular outcome [30]. Single studies were considered to
be inconsistent and imprecise and provide ‘‘low’’ or ‘‘very
low quality evidence’’ depending upon whether it was
associated with a low or high risk of bias, respectively, and
there were no other limitations.
The following levels of evidence were applied and
defined:
High quality Further research is very unlikely to
change the level of evidence and
recommendations based upon consistent
findings from at least two RCTs with low
risk of bias and generalizable to the
population in question. There are
sufficient data with narrow confidence
intervals. There are no known or
suspected reporting biases.
Moderate quality Further research is likely to have an
important impact on confidence in the
estimate of effect and may change the
estimate; one of the factors is not met.
Low quality Further research is very likely to have
an important impact on confidence in
the estimate of effect and is likely to
change it; two of the factors are not
met.
Very low quality Great uncertainty about the estimate;
three of the factors are not met.
No evidence No evidence from RCTs.
Clinical relevance
Findings were determined to be clinically relevant based
upon the size of the effect only. A cut-off point of 25
points (0–100 scale) was considered to represent the
minimally clinically important change (MCIC) for pain
[70]. An effect was considered clinically significant when
the lower limit of the 95% CI was greater than this
MCIC. For the SMD, effect sizes were defined as \0.2
for small, C0.2 to 0.8 for moderate and [0.8 for large
effects [23].
Results
Description of studies
Results of the search
In total, 373 potentially relevant titles and abstracts were
identified in the search update for the three interventions
and screened for potential inclusion from the CBRG reg-
ister (Fig. 1). This represents new studies not previously
identified in the existing Cochrane reviews. After review-
ing the full text from 48 citations, 19 new publications
were identified, representing 14 new studies on CAM
published since the respective Cochrane reviews.
Included studies
Spinal manipulative therapy
Studies were searched in the CBRG register from January
2000, which resulted in the identification of 209 new
studies potentially fulfilling the inclusion criteria. After
reviewing the full text of 22 articles, 12 articles were
included [13, 14, 16, 26, 33–35, 37, 52, 59, 60, 77]
representing eight RCTs fulfilling the inclusion criteria
[16, 26, 35, 37, 52, 59, 60, 77]. Multiple publications
were identified for Gudavalli et al. [13, 14, 37] and
Muller et al. [33, 34, 60]. The long-term study for Muller
and Giles [60] was used in subsequent referencing, while
the principal study from Gudavalli et al. [37] was refer-
enced. None of the 39 RCTs from the Cochrane review
fulfilled the inclusion criteria; thus, all included publica-
tions on SMT were published in the last decade [3]. All
of the earlier publications, which included chronic LBP,
examined a mixed population, except for two studies.
These were also excluded because one study examined a
post-surgical population [68], while the other study [62]
examined just one SMT treatment in the ‘‘manipulation’’
arm of the trial which also included weekly injections. In
total, 1,393 patients were examined in the eight RCTs
identified. Sample sizes ranged from 30 to 323 [median
178 (IQR 97–240)]. Treatment consisted of manipulative,
mobilization, or muscle energy techniques and was con-
ducted by physical or manual therapists in most studies
[26, 35, 59], chiropractors [33, 34, 37, 60, 77] or osteo-
paths [16, 52].
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Acupuncture
Studies were searched in the CBRG register from January
2003, which resulted in the identification of 133 new
studies potentially fulfilling the inclusion criteria. After
reviewing the full text of 26 articles, seven RCTs were
found to fulfil the inclusion criteria [11, 40, 42, 43, 60, 64,
78], one of which is included with another intervention
(SMT) and also represents the long-term follow-up of an
earlier study included in the Cochrane review [60]. Of the
35 RCTs included in the Cochrane review [31], 15 publi-
cations representing 14 RCTs fulfilled the inclusion criteria
[15, 22, 24, 33, 34, 36, 38, 46, 49, 50, 53, 57, 58, 67, 79].
Multiple publications were identified for Brinkhaus et al.
[9–11], Haake et al. [39, 40], Mendelson et al. [56, 57] and
Muller and Giles [33, 34, 60] which represent protocols
and preliminary or earlier findings. The most prominent of
these publications are cited. In total, 20 RCTs were
included and 5,590 patients were examined. Sample sizes
ranged from 17 to 3,093 [median 56 (IQR 50–110)].
Herbal medicine
Studies were searched in the CBRG register from January
2005, which resulted in the identification of 31 new studies
potentially fulfilling the inclusion criteria. After reviewing
the titles and abstracts, no new studies were included. Of
the ten RCTs included in the Cochrane Review, [32] seven
Potentially relevant citations retrieved in the search update (n=373) 
Acupuncture (n=133) 
Herbal medicine (n=31) 
Spinal manipulative therapy (n=209) 
Citations evaluated (n=48) 
Acupuncture (n=26) 
Herbal medicine (n=0) 
Spinal manipulative therapy (n=22)
Publications included (n=19) 
Acupuncture (n=7) 
Herbal medicine (n=0) 
Spinal manipulative therapy (n=12) 
Citations excluded on basis 
of title and abstract (n=325) 
Excluded (n=29) 
Mixed population (n=11)  
Specific LBP (n=3) 
Already in Cochrane review (n=3) 
No randomization (n=2) 
Results not reported separately  
     for the low-back (n=4) 
No full report (n=1) 
Not acupuncture (n=4) 
Prevention study (n=1) 
Excluded (n=5) 
Multiple citations for the same RCT (n=4) 
Article included in multiple interventions (n=1) 
RCTs included (n=35) 
Acupuncture (n=20) 
Herbal medicine (n=7) 
Spinal manipulative therapy (n=8)
RCTs from existing Cochrane reviews 
Acupuncture (n=14) 
Herbal medicine (n=7) 
Spinal manipulative therapy (n=0) 
Fig. 1 Selection process for
articles on complementary and
alternative medicine (CAM)
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RCTs fulfilled the inclusion criteria [17–21, 27, 45]. In
total, 1,315 patients were examined. Sample sizes ranged
from 88 to 320 [median 197 (IQR 118–228)]. Five RCTs
compared herbal medicine, consisting of willow bark [17],
a capsicum plaster [27, 45], or Harpagophytum [18, 21] to
a placebo. Two RCTs compared herbal medicine, consist-
ing of willow bark [19], or Harpagophytum [20] to a COX-
2 inhibitor (Rofecoxib).
In total, 35 RCTs (8 SMT [16, 26, 35, 37, 52, 59, 60,
77], 20 acupuncture [11, 15, 22, 24, 36, 38, 40, 42, 43, 46,
49, 50, 53, 57, 58, 60, 64, 67, 78, 79], 7 herbal medicine
[17–21, 27, 45]) fulfilled the inclusion criteria.
A detailed description of the included and excluded
CAM studies are available in Appendix 1 and 2 of Elec-
tronic Supplementary Material.
Risk of bias
An overview of the risk of bias can be found in Table 1.
Spinal manipulative therapy
Two studies were considered to have a low risk of bias [26,
52]. Two studies were excluded from the meta-analyses
because of a fatal flaw [16, 60]. In the study by Chown
et al. [16], overall, only 41 and 27% of the participants
responded at the 6-week- and 12-month follow-up mea-
surements, respectively. In the study by Muller and Giles
[60], drop-out at the first follow-up period was 49% for
medication and 52% for acupuncture [60].
Acupuncture
Eight studies were considered to have a low risk of bias
[11, 15, 40, 42, 50, 58, 64, 79]. In total, two studies were
considered to have fatal flaws, one of which is described
above [36, 60]. Another study was considered to have a
fatal flaw because the two groups examined were funda-
mentally different at baseline for all the major outcome
variables [36].
Herbal medicine
All seven studies included in this review were considered
to have a low risk of bias [17–21, 27, 45]. Thus, in total, 17
RCTs (2 SMT [26, 52], 8 acupuncture [11, 15, 40, 42, 50,
58, 64, 79], 7 herbal medicine [17–21, 27, 45]) were
thought to have a low risk of bias. The most prevalent
methodological shortcomings, which were identified in
well over half of the studies, were the lack of description
on the allocation procedure and use of co-interventions or
whether compliance with the protocol was considered
acceptable. Most studies conducted intention-to-treat
analyses, which could be defined here as a complete case
analysis. For virtually all studies, missing data were not
imputed. In most of the SMT studies, neither the patient or
care provider was blinded, as opposed to acupuncture and
herbal medicine.
Effects of interventions
Spinal manipulative therapy
In total, six RCTs without a fatal flaw (2 with a low risk of
bias) were included which examined the effects of SMT
versus sham SMT [52], ineffectual or passive modalities
[35, 59], SMT plus an intervention versus the intervention
alone [52] and versus any other intervention [26, 35, 37,
77]. Data were available for pain [26, 35, 37, 52, 59, 77],
and functional status, consisting of the ODI [35, 59] and
RMDQ [26, 37, 52, 77]. One RCT examined perceived
recovery, but analysed it as a continuous outcome [26]. A
summary of the effect estimates can be found in Table 2. In
addition, figures pertaining to the meta-analyses are
available for all the studied interventions in Appendix 3 of
Electronic Supplementary Material.
Versus no treatment or waiting list control No studies
examined this contrast.
Versus sham, placebo or passive modalities In total, 3
RCTs (1 with a low risk of bias [52]) were identified, which
compared SMT to care consisting of an educational booklet
[35], sham manipulation [52] and ultrasound [59]. For pain,
data could be pooled for two studies at 3 months only
providing very low-quality evidence (serious limitations,
indirect, imprecise), which demonstrated no significant
effect (MWD 1.81, 95% CI -7.13 to 10.75) [35, 52]. Only
one study measured the long-term effects, which demon-
strated no significant effect (very low quality evidence)
[35]. The only study with a low risk of bias demonstrated
no significant effect at the short-term or intermediate fol-
low-up (low quality evidence) [52]. For functional status,
data could be pooled at all follow-up measurements. A
moderate, significant effect was observed at 1 month from
two RCTs [52, 59] providing very low-quality evidence
(serious limitations, indirect, imprecise) in favour of SMT
(SMD -0.36, 95% CI -0.66 to -0.06); however, the only
study with a low risk of bias demonstrated no significant
effect (low quality evidence) [52]. At all other follow-up
measurements, no significant effect was observed, also
when examined for risk of bias. No studies reported
recovery.
SMT plus an intervention versus intervention alone One
RCTs (with a low risk of bias [52]) was identified, which
1218 Eur Spine J (2010) 19:1213–1228
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Table 1 Risk of bias for studies on complementary and alternative medicine
Author A B C D E F G H I J K Total Comments
Spinal manipulative therapy
Chown et al. [16]a ? ? ? - - - ? - - ? ? 3 Fatal flaw
Ferreira et al. [26] ? ? ? - - - ? ? ? ? ? 8
Goldby et al. [35] ? ? ? - - - ? - ? ? ? 4
Gudavalli et al. [37]b ? ? ? - - - ? ? - ? ± 4?
Licciardone et al. [52] ? ? ? ? - ? - ? - ? ? 6
Mohseni-Bandpei et al. [59] ? ? ? - - - ? ? - ? ? 2
Muller and Giles [60]c ? ? ? - - - ? - - ? ? 4 Fatal flaw
Wilkey et al. [77] ? ? - - - - ? - ? ? ? 3
Acupuncture
Brinkhaus et al. [10, 11] ? ? ? - - - ? ? ? ? ? 6
Carlsson and Sjolund [15]d ? ? ? ? - ? ? ? ± ? ? 6?
Coan et al [22] ? ? ? - - - ? - - - - 2
Ding [24] ? - ? ? - ? ? ? ? ? - 4
Giles and Muller [33]c ? ? ? - - - ? ? - ? ? 6 Fatal flaw
Giles and Muller [34]c ? ? ? - - - ? - - ? - 2 Fatal flaw
Grant et al. [36]e ? ? - - - - ? ? ? ? ? 5 Fatal flaw
Gunn et al. [38] - ? ? - - - ? ? ? - - 1
Haake et al. [40] ? ? ? ? - ? ? ? ? ? ? 8
Itoh et al. [42] ? ? ? ? - ? ? ? - ? ? 6
Itoh et al. [43] ? ? ? ? - ? ? ? - ? ? 5
Kerr et al. [46]f ? ? ? ? - ? ? ? - ? - 4
Lehmann et al. [49] ? ? ? - - - ? ? - ? - 2
Leibing et al. [50] ? ? ? ? - ? ? ? - ? ? 7
MacDonald et al. [53] ? ? ? ? - ? ? ? ? ? ? 4
Mendelson et al. [57] ? ? ? ? - ? ? ? ? ? - 5
Meng et al. [58]g ? ? ± - - - ? ? ? ? ? 6?
Muller and Giles [60]c ? ? ? - - - ? - - ? ? 5 Fatal flaw
Sator-Katzenschlager et al. [64] ? ? ? ? ? ? ? ? ? ? ? 8
Thomas and Lundberg [67] ? ? ? - - - - ? ? ? ? 4
Witt et al. [78] ? ? ? - - - ? ? ? ? ? 4
Yeung et al. [79] ? ? ? - - - ? ? ? ? ? 7
Herbal medicine
Chrubasik et al. [20] ? ? ? ? ? ? ? ? ? ? ? 8
Chrubasik et al. [19] ? ? ? - - - ? ? ? ? - 6
Chrubasik et al. [17] ? ? - ? ? ? ? ? ? ? ? 7
Chrubasik et al. [18] ? ? ? ? ? ? ? ? ? ? ? 8
Chrubasik et al. [21] ? ? ? ? ? ? ? ? ? ? - 7
Frerick et al. [27] ? ? ? ? ? ? ? ? ? ? ? 6
Keitel et al. [45] ? ? ? ? ? ? ? ? ? ? ? 7
Criteria items: A Was the method of randomization adequate? B Was the treatment allocation concealed? C Were the groups similar at baseline regarding
the most important prognostic indicators? D Was the patient blinded to the intervention? E Was the care provider blinded to the intervention? F Was the
outcome assessor blinded to the intervention? G Were co-interventions avoided or similar? H Was the compliance acceptable in all groups? I Was the
drop-out rate described and acceptable? J Was the timing of the outcome assessment similar in all groups? K Were all randomized participants analysed in
the group to which they were allocated?
a Only 41 and 27% of the participants responded at the 6-week and 12-month follow-up measurements, respectively
b ITT analysis was conducted only at the first follow-up measurement (at 4 weeks); subsequent analyses were ‘‘per-protocol’’
c Muller et al. is the long-term follow-up to Giles et al.; 52% drop-out during treatment in the acupuncture group, 51 and 44% of the data available for the
medication group at 9 weeks and 12 months, respectively; Overall, just 60 and 54% of the data were available for the follow-up measurements
d ITT analysis at 1 month; subsequent measurements did not include all subjects
e The two groups were fundamentally different at baseline with respect to all principal outcome measures, which was not corrected for in the analyses
f Co-interventions might have influenced the results: 76 and 66.7% of the patients were followed for the short-term and intermediate follow-ups
g Small difference in pain baseline measure; important difference in RDQ for the acupuncture and control group
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examined the effects of SMT when added to usual care.
This study demonstrated significant pain relief at 3 months
in favour of SMT (MWD -14.20, 95% CI -26.89 to
-1.51) [low quality evidence (indirect, imprecise)]. No
other significant association was found. For functional
status, no significant effect was found at any interval (low
quality evidence).
Versus any other intervention In total, four RCTs (1 with
a low risk of bias [26]) were identified, which included
interventions, such as exercise [26, 35, 37] and treatment in
a hospital outpatient pain clinic [77]. Data could be pooled
for pain at every follow-up measurement, except 6 months.
A small, significant, but not clinically relevant effect was
observed at 1 month from two RCTs [37, 77] with a high
risk of bias in favour of SMT (MWD -3.28, 95% CI -5.73
to -0.82) [low quality evidence (serious limitations, indi-
rect)]. At 3 and 12 months, no significant effect was
observed [very low quality evidence (serious limitations,
indirect, inconsistent)]. For functional status, there was
Table 2 Summary effect estimates for spinal manipulative therapy
Outcome or subgroup Studies Participants Statistical method Effect estimate
1. Spinal manipulative therapy versus no treatment or waiting list control
No studies were identified
2. Spinal manipulative therapy versus sham/placebo/passive modalities
2.1 Pain 3 Mean difference (IV, Random, 95% CI) Subtotals only
2.1.1 Pain at 1 month 2 177 Mean difference (IV, Random, 95% CI) -4.32 [-25.36, 16.73]
2.1.2 Pain at 3 months 2 177 Mean difference (IV, Random, 95% CI) 1.81 [-7.13, 10.75]
2.1.3 Pain at 6 months 3 225 Mean difference (IV, Random, 95% CI) -0.41 [-15.05, 14.23]
2.1.4 Pain at 12 months 1 102 Mean difference (IV, Random, 95% CI) 5.20 [-9.56, 19.96]
2.2 Disability 3 Std. Mean difference (IV, Random, 95% CI) Subtotals only
2.2.1 Disability at 1 month 2 177 Std. Mean Difference (IV, Random, 95% CI) -0.36 [-0.66, -0.06]
2.2.2 Disability at 3 months 2 177 Standard mean difference (IV, Random, 95% CI) 0.13 [-0.19, 0.45]
2.2.3 Disability at 6 months 3 225 Standard mean difference (IV, Random, 95% CI) 0.06 [-0.26, 0.39]
2.2.4 Disability at 12 months 1 102 Standard mean difference (IV, Random, 95% CI) 0.13 [-0.30, 0.57]
2.3 Recovery 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
3. Spinal manipulative therapy ? intervention versus intervention alone
3.1 Pain 1 Mean Difference (IV, Random, 95% CI) Subtotals only
3.1.1 Pain at 1 month 1 59 Mean difference (IV, Random, 95% CI) -8.80 [-21.43, 3.83]
3.1.2 Pain at 3 months 1 52 Mean difference (IV, Random, 95% CI) -14.20 [-26.89, -1.51]
3.1.3 Pain at 6 months 1 47 Mean difference (IV, Random, 95% CI) -4.90 [-18.68, 8.88]
3.1.4 Pain at 12 months 0 0 Mean difference (IV, Random, 95% CI) Not estimable
3.2 Disability 1 Standard mean difference (IV, Random, 95% CI) Subtotals only
3.2.1 Disability at 1 month 1 59 Std. Mean Difference (IV, Random, 95% CI) -0.27 [-0.84, 0.29]
3.2.2 Disability at 3 months 1 52 Standard mean difference (IV, Random, 95% CI) 0.04 [-0.55, 0.63]
3.2.3 Disability at 6 months 1 47 Standard mean difference (IV, Random, 95% CI) -0.19 [-0.80, 0.43]
3.2.4 Disability at 12 months 0 0 Standard mean difference (IV, Random, 95% CI) Not estimable
3.3 Recovery 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
4. Spinal manipulative therapy versus any other intervention
4.1 Pain 4 Mean difference (IV, Random, 95% CI) Subtotals only
4.1.1 Pain at 1 month 2 265 Mean difference (IV, Random, 95% CI) -3.28 [-5.73, -0.82]
4.1.2 Pain at 3 months 4 580 Mean difference (IV, Random, 95% CI) -1.91 [-5.37, 1.55]
4.1.3 Pain at 6 months 3 524 Mean difference (IV, Random, 95% CI) 1.04 [-10.50, 12.58]
4.1.4 Pain at 12 months 3 530 Mean difference (IV, Random, 95% CI) -0.32 [-4.92, 4.29]
4.2 Disability 4 Standard mean difference (IV, Random, 95% CI) Subtotals only
4.2.1 Disability at 1 month 2 226 Standard mean difference (IV, Random, 95% CI) -0.49 [-1.41, 0.43]
4.2.2 Disability at 3 months 4 579 Standard mean difference (IV, Random, 95% CI) -0.20 [-0.54, 0.14]
4.2.3 Disability at 6 months 3 528 Standard mean difference (IV, Random, 95% CI) -0.05 [-0.34, 0.24]
4.2.4 Disability at 12 months 3 529 Standard mean difference (IV, Random, 95% CI) 0.04 [-0.15, 0.23]
4.3 Recovery 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
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substantial heterogeneity at the short-term and intermediate
follow-up. Three RCTs reported data for the long-term
follow up, but the effect was non-significant (very low
quality evidence) [26, 35, 37]. In a sensitivity analysis, the
effects of SMT on pain and functional status were exam-
ined in those studies which compared SMT to exercise only
[26, 35, 37]. A small significant, but not clinically relevant
effect was seen for pain relief at 1 month in favour of SMT
(1 RCT; MWD -6.00; 95% CI -11.50 to -0.50) (very
low quality evidence). No significant effect was seen for
functional status at any of the follow-up measurements
(very low quality evidence). The only study with a low risk
of bias demonstrated no significant effect on pain relief or
functional improvement at any of the intermediate or long-
term follow-up measurements (data were not collected for
the short-term follow-up) (low quality evidence) [26].
Versus other types of SMT No studies examined this
contrast.
Acupuncture
In total, 18 RCTs without a fatal flaw (8 with a low risk of
bias) were identified which examined the effects of acu-
puncture versus waiting list control [22, 67, 78], sham
acupuncture [11, 40, 42, 50, 57], placebo including TENS
[15, 46, 49, 53], acupuncture plus another intervention
versus the intervention alone [38, 50, 58, 78, 79], versus
any other intervention [40] and other types of acupuncture
[24, 43, 64]. Data were available which examined pain [11,
15, 22, 40, 42, 43, 46, 49, 50, 53, 57, 58, 64, 67, 78, 79]. In
one RCT data were not extracted because pain was
reported as the number of words describing the intensity or
unpleasantness of the pain, and functional status was
defined both gonometrically and as number of activities
causing less than 50% pain [67]. In another study the LBP
rating scale was used [55], which is a 130-point combi-
nation outcome measure, consisting of back and leg pain
and a disability and physical impairment index and there-
fore, was not clear how this would translate to the other
functional scales. Ten RCTs were identified, which
examined functional status [11, 40, 42, 43, 49, 50, 53, 58,
67, 78], as measured by the RMDQ [42, 43, 58], HFAQ
[40] and PDI [11, 50]. Four RCTs (all with a high risk of
bias) examined recovery [15, 22, 46, 67], but the data were
deemed unreliable in all but one study [15] due to for
example, a large percentage of drop-outs [46], and also
noted elsewhere [31] concerning the study by Thomas and
Lundberg [67]. A summary of the effect estimates can be
found in Table 3.
Versus no treatment or waiting list control Only one
study (with a low risk of bias [11]) was identified for which
data could be extracted and interpreted. A large significant
effect was observed at 8 weeks for pain relief in favour of
acupuncture (MWD -24.10, 95% CI -31.52 to -16.68)
and for functional status (SMD -0.61, 95% CI -0.90 to
-0.33) (low quality evidence).
Versus sham, placebo or passive modalities In total,
seven RCTs (5 with a low risk of bias [11, 15, 40, 42, 50])
were identified [11, 15, 40, 42, 46, 50, 57]. It was not
possible to pool data due to an extreme outlier, which
demonstrated a large significant and clinically relevant
effect (MWD -42.30, 95% CI -53.29 to -31.31 at
1 month follow-up) (low quality evidence) [42]. This was a
small study (n = 19), which examined sham acupuncture
in elderly subjects. In a subsequent post hoc analysis, it was
decided to exclude this study, which allowed data to be
pooled at all follow-up measurements. For pain relief, a
small, significant, but not clinically relevant effect was
observed at the short-term and intermediate follow-ups in
favour of acupuncture (MWD -5.88, 95% CI -11.20 to
-0.55; -7.27 95% CI -12.66 to -1.89; -3.26, 95% CI
-6.28 to -0.23, respectively) [moderate quality evidence
(serious imprecision)]. Similarly, a significant, but small
clinical effect was observed for functional status at the
short-term and intermediate follow-up measurements
(SMD -0.18, 95% CI -0.32 to -0.04; -0.28, 95% CI
-0.41 to -0.16; -0.27, 95% CI -0.40 to -0.15, respec-
tively) [low quality evidence (serious imprecision, incon-
sistent)]. In total, three RCTs examined recovery for the
short-term and intermediate follow-up measurements [15,
40, 46]; however, one of these studies presented the data as
a continuous outcome [40]. Only one of these studies was
thought to have a low risk of bias, which demonstrated no
significant effect at any of these follow-up measurements
(low quality evidence) [15].
Acupuncture plus an intervention versus intervention
alone In total, five RCTs (3 with a low risk of bias [50,
58, 79]) were identified, which examined the therapeutic
effects of acupuncture in addition to another therapy
(physiotherapy [50], standard medical care [38, 58, 78],
and exercise [79]). A significant, but not clinically relevant
effect was observed for pain relief at 1, 3 and 12 months,
but not 6 months (for which there was no data) (MWD
-9.80, 95% CI -14.93 to -4.67; -16.91, 95% CI -25.18
to -8.64; -14.00, 95% CI -21.83 to -6.17, respectively)
[low quality evidence (indirect, imprecise)]. A strong,
significant clinically relevant effect was observed for
functional status at 1 and 3 months in favour of acupunc-
ture (SMD -1.04, 95% CI -1.46 to -0.61; -0.66, 95% CI
-0.74 to -0.58, respectively) [low quality evidence
(indirect, imprecise)]. A significant effect was observed for
recovery at 3 months in one study with a high risk of bias
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Table 3 Summary effect estimates for acupuncture
Outcome or subgroup Studies Participants Statistical method Effect estimate
5 Acupuncture versus no treatment or waiting list control
5.1 Pain 1 214 Mean difference (IV, Random, 95% CI) -24.10 [-31.52, -16.68]
5.1.1 Pain at 1 month 0 0 Mean difference (IV, Random, 95% CI) Not estimable
5.1.2 Pain at 3 months 1 214 Mean difference (IV, Random, 95% CI) -24.10 [-31.52, -16.68]
5.1.3 Pain at 6 months 0 0 Mean difference (IV, Random, 95% CI) Not estimable
5.1.4 Pain at 12 months 0 0 Mean Difference (IV, Random, 95% CI) Not estimable
5.2 Disability 1 214 Standard mean difference (IV, Random, 95% CI) -0.61 [-0.90, -0.33]
5.2.1 Disability at 1 month 0 0 Standard mean difference (IV, Random, 95% CI) Not estimable
5.2.2 Disability at 3 months 1 214 Std. Mean Difference (IV, Random, 95% CI) -0.61 [-0.90, -0.33]
5.2.3 Disability at 6 months 0 0 Standard mean difference (IV, Random, 95% CI) Not estimable
5.2.4 Disability at 12 months 0 0 Standard mean difference (IV, Random, 95% CI) Not estimable
5.3 Recovery 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
6 Acupuncture versus sham/placebo/passive modalities
6.1 Pain 6 Mean difference (IV, Random, 95% CI) Subtotals only
6.1.1 Pain at 1 month 4 918 Mean difference (IV, Random, 95% CI) -5.88 [-11.20, -0.55]
6.1.2 Pain at 3 months 4 1076 Mean difference (IV, Random, 95% CI) -7.27 [-12.66, -1.89]
6.1.3 Pain at 6 months 3 989 Mean difference (IV, Random, 95% CI) -3.26 [-6.28, -0.23]
6.1.4 Pain at 12 months 2 290 Mean difference (IV, Random, 95% CI) -4.74 [-10.50, 1.02]
6.2 Disability 3 Standard mean difference (IV, Random, 95% CI) Subtotals only
6.2.1 Disability at 1 month 1 745 Standard mean difference (IV, Random, 95% CI) -0.18 [-0.32, -0.04]
6.2.2 Disability at 3 months 3 1044 Standard mean difference (IV, Random, 95% CI) -0.28 [-0.41, -0.16]
6.2.3 Disability at 6 months 2 962 Standard mean difference (IV, Random, 95% CI) -0.27 [-0.40, -0.15]
6.2.4 Disability at 12 months 2 290 Standard mean difference (IV, Random, 95% CI) -0.22 [-0.46, 0.03]
6.3 Recovery 2 Risk ratio (M-H, Random, 95% CI) Subtotals only
6.3.1 Recovery at 1 month 2 90 Risk ratio (M-H, Random, 95% CI) 1.92 [0.41, 9.09]
6.3.2 Recovery at 3 months 1 50 Risk ratio (M-H, Random, 95% CI) 3.53 [0.91, 13.62]
6.3.3 Recovery at 6 months 2 83 Risk ratio (M-H, Random, 95% CI) 1.82 [0.72, 4.61]
6.3.4 Recovery at 12 months 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
7 Acupuncture ? intervention versus intervention alone
7.1 Pain 3 Mean difference (IV, Random, 95% CI) Subtotals only
7.1.1 Pain at 1 month 2 99 Mean difference (IV, Random, 95% CI) -9.80 [-14.93, -4.67]
7.1.2 Pain at 3 months 3 185 Mean difference (IV, Random, 95% CI) -16.91 [-25.18, -8.64]
7.1.3 Pain at 6 months 0 0 Mean difference (IV, Random, 95% CI) Not estimable
7.1.4 Pain at 12 months 1 86 Mean Difference (IV, Random, 95% CI) -14.00 [-21.83, -6.17]
7.2 Disability 4 Standard mean difference (IV, Random, 95% CI) Subtotals only
7.2.1 Disability at 1 month 2 99 Standard mean difference (IV, Random, 95% CI) -1.04 [-1.46, -0.61]
7.2.2 Disability at 3 months 4 2824 Standard mean difference (IV, Random, 95% CI) -0.66 [-0.74, -0.58]
7.2.3 Disability at 6 months 0 0 Standard mean difference (IV, Random, 95% CI) Not estimable
7.2.4 Disability at 12 months 1 131 Standard mean difference (IV, Random, 95% CI) -0.28 [-0.66, 0.09]
7.3 Recovery 1 Risk ratio (M-H, Random, 95% CI) Subtotals only
7.3.1 at 1 month 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
7.3.2 at 3 months 1 56 Risk ratio (M-H, Random, 95% CI) 5.90 [1.96, 17.70]
7.3.3 at 6 months 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
7.3.4 at 12 months 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
8 Acupuncture versus any other intervention
8.1 Pain 1 Mean difference (IV, Random, 95% CI) Subtotals only
8.1.1 Pain at 1 month 1 731 Mean difference (IV, Random, 95% CI) -8.50 [-11.04, -5.96]
8.1.2 Pain at 3 months 1 734 Mean difference (IV, Random, 95% CI) -9.40 [-12.13, -6.67]
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in favour of acupuncture (RR 5.90; 95% CI 1.96–17.70)
(very low quality evidence) [38]. This was a study which
examined the effects of acupuncture in exclusively male
subjects who had failed traditional medical or surgical
therapy. The long-term follow-up measurement was highly
variable and therefore, not presented.
Versus any other intervention Only one study (with a low
risk of bias [40]) examined the effects of acupuncture versus
another intervention, namely standard care, consisting of
treatment by a physician or physiotherapist and comprised a
‘‘multimodal treatment program’’. Patients in the acupunc-
ture group were allowed ‘‘rescue medication’’ for acute
episodes consisting of a short course of NSAIDs (no more
than 2 days per week). A statistically, but not clinically
relevant effect was observed for pain at the short-term and
intermediate follow-ups (MWD -8.50, 95% CI -11.04 to
-5.96; -9.40, 95% CI -12.13 to -6.67; -12.10, 95% CI
-15.25 to -8.95, respectively) (low quality evidence). In
contrast, a moderate statistically significant and clinically
relevant effect was observed for functional status at the
short-term and intermediate follow-ups in favour of
acupuncture (SMD -0.53, 95% CI -0.67 to -0.38; -0.64,
95% CI -0.79 to -0.49; -0.76, 95% CI -0.91 to -0.61,
respectively) (low quality evidence). Recovery was exam-
ined but analysed as a continuous variable.
Versus other types of acupuncture One small study
(n = 35) (with a high risk of bias) examined the effect of
standard acupuncture versus superficial (acupuncture sen-
sation de qi) and deep needling at trigger points in patients
65 years of age and older (very low quality evidence) [43].
There were no significant differences between the groups at
the end of either of two treatment phases. Another study
(n = 61) (with a low risk of bias) examined the effect of
auricular electroacupuncture to conventional manual
auricular acupuncture (low quality evidence) [64]. Elec-
troacupuncture resulted in significantly and clinically more
pain relief and functional improvement at the short and
intermediate phase compared with manual acupuncture.
Another study examined the effects of an ancient versus
regular needling technique, but it was unclear whether the
assessment was conducted immediately following treat-
ment or at 2 months [24].
Herbal medicine
In total, seven RCTs (all with a low risk of bias and without
a fatal flaw) were included in the analyses [17–21, 27, 45].
A summary of the effect estimates can be found in Table 4.
Versus no treatment or waiting list control No studies
examined this contrast.
Versus sham, placebo or passive modalities In total, five
RCTs examined this contrast, consisting of placebo tablets
or plasters [17, 18, 21, 27, 45]. The principal outcome
measure was perceived recovery at 1 month. Three of the
studies defined recovery as the number of patients pain-free
and who had not used Tramadol in the last week of the trial
[17, 18, 21]. Data could not be pooled due to heterogeneity;
therefore, in a post hoc analysis data were examined by the
specific type of herbal medicine.
Harpagophytum versus placebo In total, two RCTs were
identified, which demonstrated a non-significant effect in
favour of the herbal medicine for short-term recovery (RR
3.02, 95% CI 0.51–17.91) [moderate quality evidence
(indirect; imprecise)] [18, 21].
Capsicum plaster (cayenne pepper) versus placebo In
total, two RCTs were identified, which demonstrated a
small, significant effect in favour of the herbal medicine for
short-term recovery (RR 1.59, 95% CI 1.37–1.85) [mod-
erate quality evidence (limitations)] [27, 45].
Willow bark (salix alba) versus placebo One RCT was
identified, which demonstrated a strong, significant effect
in favour of the herbal medicine for short-term recovery
(RR 6.75, 95% CI 2.49–18.28) (low quality evidence) [17].
Table 3 continued
Outcome or subgroup Studies Participants Statistical method Effect estimate
8.1.3 Pain at 6 months 1 741 Mean difference (IV, Random, 95% CI) -12.10 [-15.25, -8.95]
8.1.4 Pain at 12 months 0 0 Mean difference (IV, Random, 95% CI) Not estimable
8.2 Disability 1 Standard mean difference (IV, Random, 95% CI) Subtotals only
8.2.1 Disability at 1 month 1 731 Standard mean difference (IV, Random, 95% CI) -0.53 [-0.67, -0.38]
8.2.2 Disability at 3 months 1 734 Standard mean difference (IV, Random, 95% CI) -0.64 [-0.79, -0.49]
8.2.3 Disability at 6 months 1 741 Standard mean difference (IV, Random, 95% CI) -0.76 [-0.91, -0.61]
8.2.4 Disability at 12 months 0 0 Standard mean difference (IV, Random, 95% CI) Not estimable
8.3 Recovery 0 0 Risk ratio (M-H, Random, 95% CI) Not estimable
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Herbal medicine plus an intervention versus intervention
alone No studies examined this contrast.
Versus any other intervention In total, two RCTs exam-
ined this contrast, which compared herbal medicine to
COX-2 inhibitors (Rofecoxib) [19, 20]. The outcomes, pain
and perceived recovery, were examined at 1 month only.
No data were available for the intermediate or long-term
follow-up. Data could not be pooled for the group due to
heterogeneity; therefore, data were analysed per specific
type of herbal medicine.
Willow bark (salix alba) versus Rofecoxib One RCT was
identified, which demonstrated a small, significant effect in
favour of the herbal medicine for pain relief (MWD)
-6.00, 95% CI -11.45 to -0.55), but a non-significant
effect in favour of Rofecoxib for recovery (RR 0.87, 95%
CI (0.69 to 1.10) (low quality evidence) [19].
Harpagophytum versus Rofecoxib One RCT was identi-
fied, which demonstrated no significant effect for pain
relief (MD 0.00, 95% CI -3.09 to 3.09) or for recovery
(RR 1.00, 95% CI 0.38–2.61) (low quality evidence) [20].
Discussion
The lack of studies with a low risk of bias, especially in
regard to SMT precludes any strong conclusions; however,
the principal findings, which are based upon low- to very
low-quality evidence, suggest that SMT does not provide a
more clinically beneficial effect compared with sham,
passive modalities or any other intervention for treatment
of chronic LBP. There is evidence, however, that acu-
puncture provides a short-term clinically relevant effect
when compared with a waiting list control or when acu-
puncture is added to another intervention. Although there
are some good results for individual herbal medicines in
short-term individual trials, the lack of homogeneity across
studies did not allow for a pooled estimate of the effect. In
general, these results are in agreement with other recent
systematic reviews on SMT [2, 25], but in contrast with
others [12, 51, 74]. These results are also in agreement with
recent reviews on acupuncture [1, 31, 54] and herbal
medicine [32].
Perhaps some criticism might be levelled at our defini-
tion of chronic LBP. To our knowledge, this is the first
review to exclusively examine subjects suffering LBP for
more than 3 months. Previous reviews, especially for
spinal manipulation, have included studies with a mixed
population, e.g. sub-acute and chronic, in many cases,
limiting the analysis to those studies in which the majority
had chronic LBP [3, 12]. Furthermore, data for exclusively
chronic LBP were not presented. This decision had definite
consequences for the number of studies included in this
review because a large majority of studies investigating
SMT, and to a lesser extent acupuncture, examined mixed
populations. This decision was not taken lightly. In our
estimation, the inclusion of studies investigating exclu-
sively chronic LBP allows for a better estimation of the
effect of these interventions. However, this also meant
excluding some studies with a low risk of bias, which have
demonstrated a positive effect of CAM [69]. At best and
based upon the findings from this review, CAM therapies
Table 4 Summary effect estimates for herbal medicine
Outcome or subgroup Studies Participants Statistical Method Effect Estimate
9 Herbal medicine versus no treatment or waiting list control
No studies were identified
10 Herbal medicine versus sham/placebo/passive modalities
10.1 Pain 0 0 Mean difference (IV, Random, 95% CI) Not estimable
10.2 Disability 0 0 Standard mean difference (IV, Random, 95% CI) Not estimable
10.3 Recovery 5 Risk ratio (M-H, Random, 95% CI) Subtotals only
10.3.1 Recovery at 1 month 5 841 Risk ratio (M-H, Random, 95% CI) 1.92 [1.31, 2.81]
11 Herbal medicine ? intervention versus intervention alone
No studies were identified
12 Herbal medicine versus any other intervention
12.1 Pain 2 271 Mean difference (IV, Random, 95% CI) -2.56 [-8.38, 3.25]
12.1.1 Pain at 1 month 2 271 Mean difference (IV, Random, 95% CI) -2.56 [-8.38, 3.25]
12.2 Disability 0 0 Mean difference (IV, Random, 95% CI) Not estimable
12.3 Recovery 2 Risk ratio (M-H, Random, 95% CI) Subtotals only
12.3.1 Recovery at 1 month 2 271 Risk ratio (M-H, Random, 95% CI) 0.88 [0.70, 1.10]
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tend to have a short-term effect; therefore, studies which
investigated a mixed population might overestimate these
effects because patients with a shorter duration of LBP
might be more likely to respond to treatment. This is
consistent with the observation that longer duration of pain
is a consistent predictor of a worse outcome for numerous
musculoskeletal complaints [6, 7, 44, 47, 65, 71–73].
Principal limitations include the relatively few studies
with a low risk of bias, which was most notable for SMT.
By comparison, we identified four times as many studies
for acupuncture, while all the studies for herbal medicine
had a low risk of bias. Nevertheless, despite the fact that
the quality of studies has improved in the past decade, less
than half of all studies included in this review were con-
sidered to meet the minimum requirement. Another
important limitation was the type of data used, that is, we
examined the mean and standard deviations for the indi-
vidual interventions at the various time measurements
without regard to (small) baseline differences between the
different interventions. Optimally, it would have been best
to examine within mean changes, but in many cases, these
data were not available. It is unclear what this difference in
the analysis would have meant to the overall results and
conclusions; however, we did ‘‘eyeball’’ these differences
before extracting the data. It is also open for debate whe-
ther our definition of a fatal flaw is suitable and appropriate
and whether these studies should be excluded from the
meta-analyses. This exclusion was added as a buffer in
order to prevent a biased assessment. Although a sensitivity
analysis could have been conducted in order to determine
to what extent these studies had on the overall effect,
sensitivity analyses are by definition post hoc and there-
fore, also subject to potential bias. Based upon our
assessment, two of the three studies found to have a fatal
flaw, also had a high risk of bias [16, 36] and presented
data as a median and interquartile range, presumably due to
the skewness of the study data [36, 60]. Whether this
definition finds universal recognition remains to be dis-
cussed and is a subject for future study. In addition, there
was a limited amount of data for the primary outcome
variables. This is particularly cogent for recovery. As a
result, our analyses were limited to pain and functional
status. The limited amount of data also made it difficult to
discern whether different types of SMT (e.g. high-velocity
low amplitude techniques, such as used by most chiro-
practors, or mobilization techniques, such as used by
manual therapists or osteopaths), different types of acu-
puncture (e.g. electroacupuncture or manually-stimulated
acupuncture, or Western vs. Chinese acupuncture) or dos-
ages of herbal medicine are more effective than another.
Finally, studies were excluded if the unique contribution of
CAM could not be discerned. This means pragmatic stud-
ies, which include multiple therapies and might more
closely resemble clinical treatment, were excluded. The
effect of one such recent study with a low risk of bias,
which included SMT among other interventions (i.e.
exercise) in one of the treatment arms, demonstrated a
small significant effect on pain relief and a moderate effect
on functional improvement compared with a physician
consultation alone [61]. While these studies are vital to our
understanding, they risk being excluded from future sys-
tematic reviews.
A major strength of this review is an overview of the
effects of CAM for the treatment of chronic LBP. Ideally,
we would have liked to have compared the different CAM
interventions with one another; however, these studies are
lacking. In fact, only one study directly examined the effect
of SMT versus acupuncture and versus medication (NSA-
IDs); however, this study had a fatal flaw [60]. Alterna-
tively, we wanted to conduct indirect comparisons with the
various CAM therapies; however, there was too much
heterogeneity between studies to make for a useful
analysis.
While this review suggests a lack of benefit associated
with SMT for chronic LBP, this is not necessarily an
indictment of its efficacy. A recent study, which examined
the effects of manipulation in addition to other interven-
tions in patients with acute and subacute LBP, concluded
that outcomes are improved when patients are matched to
an intervention according to their signs and symptoms as
opposed to being randomly assigned to a particular therapy
[8]. Perhaps this indicates the need for a new generation of
clinical trials, in which sub-grouping of the participants is
taken into account.
Authors’ conclusions
In conclusion, overall, the lack of studies with a low risk of
bias precludes any strong recommendations, particularly
with regard to SMT. Randomized trials with a low risk of
bias and adequate sample sizes are direly needed.
Recommendations
Future efforts should focus on improving the quality of
studies by considering the quality items discussed in this
report. Furthermore, researchers should better define non-
specific LBP so that the studied populations are as
homogenous as possible and consider classification
schemes in which subjects are randomized to individual
therapies for which they are likely to respond.
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